Michael Mithoefer
Senior Medical Director for Medical Affairs at MAPS PBC
Key Impact
Conducted the first FDA-approved clinical trial of MDMA-assisted therapy for PTSD.
Background & Research
Michael Mithoefer is a psychiatrist and researcher world-renowned for his work with MDMA. Together with Annie Mithoefer, he has led foundational Phase 2 and Phase 3 trials investigating MDMA-assisted psychotherapy for treatment-resistant PTSD. His approach integrates internal family systems and experiential therapy, focusing on the patient's innate capacity for self-healing.
Focus Areas
MDMA TherapyPTSDHolotropic BreathworkPsychotherapy